Literature DB >> 10974542

The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation.

G M Yousef1, A Scorilas, A Magklara, A Soosaipillai, E P Diamandis.   

Abstract

The human stratum corneum chymotryptic enzyme (HSCCE; PRSS6, KLK7 gene) has been purified from human stratum corneum and is known to participate in the cell shedding process. The cDNA of the gene has previously been reported. Here, we describe the identification of 5' and 3' extensions of the published mRNA, and the complete genomic organization of the gene. KLK7 is composed of five coding exons which have similar lengths to exons of other kallikrein-like genes. The intron phases are completely conserved between this gene and other members of the kallikrein-like gene family. Precise mapping of KLK7 has indicated that it is located at chromosomal locus 19q13. 3-q13.4 between the already known genes zyme (KLK6) (centromere) and neuropsin (KLK8) (telomere). Until recently, it was thought that this gene is expressed only in the skin. We here provide evidence that KLK7 is also expressed at relatively high levels in the central nervous system, kidney, mammary and salivary glands. Its expression is up-regulated by estrogens and glucocorticoids in the breast carcinoma cell line BT-474. The cDNA and protein of this gene are homologous to sequences of other kallikrein-like genes. The gene encodes for a secreted protein. Phylogenetic analysis, the close structural similarities, and its co-localization in the same chromosomal region, suggest that the gene encoding for the stratum corneum chymotryptic enzyme is a new member of the expanded human kallikrein gene family.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974542     DOI: 10.1016/s0378-1119(00)00280-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family.

Authors:  Israel S Fernández; Ludger Ständker; Wolf Georg Forssmann; Guillermo Giménez-Gallego; Antonio Romero
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-07

2.  Kallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation.

Authors:  Changxiong J Guo; Madison R Mack; Landon K Oetjen; Anna M Trier; Martha L Council; Ana B Pavel; Emma Guttman-Yassky; Brian S Kim; Qin Liu
Journal:  J Invest Dermatol       Date:  2019-12-26       Impact factor: 8.551

Review 3.  Soluble E-cadherin: more than a symptom of disease.

Authors:  Magdalena M Grabowska; Mark L Day
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

4.  Gene network analyses point to the importance of human tissue kallikreins in melanoma progression.

Authors:  Waleska K Martins; Gustavo H Esteves; Otávio M Almeida; Gisele G Rezze; Gilles Landman; Sarah M Marques; Alex F Carvalho; Luiz F L Reis; João P Duprat; Beatriz S Stolf
Journal:  BMC Med Genomics       Date:  2011-10-27       Impact factor: 3.063

5.  The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.

Authors:  G M Yousef; A Scorilas; A Magklara; N Memari; R Ponzone; P Sismondi; N Biglia; M Abd Ellatif; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

6.  Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.

Authors:  A Scorilas; L Kyriakopoulou; D Katsaros; E P Diamandis
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

7.  Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency.

Authors:  Lakmali Munasinghage Silva; Thomas Stoll; Thomas Kryza; Carson Ryan Stephens; Marcus Lachlan Hastie; Helen Frances Irving-Rodgers; Ying Dong; Jeffrey John Gorman; Judith Ann Clements
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

8.  Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer.

Authors:  Jian Ping Du; Lin Li; Jun Zheng; Ding Zhang; Wei Liu; Wei Hong Zheng; Xiao Song Li; Ru Cheng Yao; Fangyu Wang; Sen Liu; Xiao Tan
Journal:  Oncotarget       Date:  2018-01-10

9.  Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.

Authors:  Tiphaine Delaunay; Lydia Deschamps; Meriem Haddada; Francine Walker; Antoninus Soosaipillai; Feryel Soualmia; Chahrazade El Amri; Eleftherios P Diamandis; Maria Brattsand; Viktor Magdolen; Dalila Darmoul
Journal:  Mol Oncol       Date:  2017-08-11       Impact factor: 6.603

10.  Kallikrein gene downregulation in breast cancer.

Authors:  G M Yousef; G M Yacoub; M-E Polymeris; C Popalis; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.